Nexogenix Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 20-11-2024
- Paid Up Capital ₹ 6.00 Cr
as on 20-11-2024
- Company Age 1 Year 8 Months
- Open Charges ₹ 6.00 Cr
as on 20-11-2024
- Satisfied Charges ₹ 4.20 Cr
as on 20-11-2024
About Nexogenix Lifesciences
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 6.00 Cr.
The company currently has active open charges totaling ₹6.00 Cr. The company has closed loans amounting to ₹4.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sreelatha Mamidi, Dhatri Sandinti, Yashwanth Chinta, and One other member serve as directors at the Company.
- CIN/LLPIN
U26516TS2023PTC171887
- Company No.
171887
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nexogenix Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreelatha Mamidi  | Director | 12-Apr-2023 | Current |
| Dhatri Sandinti | Director | 12-Apr-2023 | Current |
| Yashwanth Chinta | Director | 12-Apr-2023 | Current |
| Chinta Venkata | Director | 12-Apr-2023 | Current |
Financial Performance of Nexogenix Lifesciences.
Enhance accessibility to Nexogenix Lifesciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Nexogenix Lifesciences?
Unlock access to Nexogenix Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Suchita Healthcare & Research Private LimitedActive 3 years 11 monthsDhatri Sandinti is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Sep 2018 | ₹4.43 Cr | Open |
State Bank Of India Creation Date: 11 Sep 2018 | ₹1.57 Cr | Open |
Small Industries Development Bank Of India Creation Date: 08 Dec 2014 | ₹3.20 Cr | Satisfied |
How Many Employees Work at Nexogenix Lifesciences?
Unlock and access historical data on people associated with Nexogenix Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nexogenix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nexogenix Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.